Healthy men test new version of arthritis drug
NCT ID NCT06262477
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 26 times
Summary
This study tested whether a new drug called BIIB800 works similarly to an approved drug, Actemra, in the body. It involved 300 healthy male volunteers who received a single injection. The goal was to measure how the drugs are absorbed and processed, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fortrea Clinical Research Unit Inc.
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit Inc.
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Leeds, West Yorkshire, LS2 9LH, United Kingdom
Conditions
Explore the condition pages connected to this study.